Premium Nahrungsergänzungsmittel | artgerecht

Venous Thrombosis Prophylaxis – Prevention Explained

Venous thrombosis prophylaxis includes all measures taken to prevent blood clots from forming in the veins. It is especially important after surgery or during prolonged immobility.

Regular tips about health Regular tips about health

Things worth knowing about "Venous Thrombosis Prophylaxis"

Venous thrombosis prophylaxis includes all measures taken to prevent blood clots from forming in the veins. It is especially important after surgery or during prolonged immobility.

What is Venous Thrombosis Prophylaxis?

Venous thrombosis prophylaxis refers to all preventive measures designed to stop blood clots (thrombi) from forming in the veins. These clots develop most commonly in the deep veins of the legs and can lead to life-threatening complications such as a pulmonary embolism if a clot breaks free and travels to the lungs. Prophylaxis is a cornerstone of modern inpatient and postoperative care.

Who Needs Venous Thrombosis Prophylaxis?

Not everyone carries the same risk of developing a venous thrombosis. Certain conditions and situations significantly increase the risk:

Major surgical procedures, especially involving the hip, knee, or abdomen
Prolonged bed rest or immobility
Serious illnesses such as heart failure, cancer, or stroke
Pregnancy and the postpartum period
Long-distance travel with limited movement
Known clotting disorders or a family history of thrombosis
Obesity, advanced age, or use of hormonal medications (e.g., oral contraceptives)

Based on these risk factors, healthcare providers assess which preventive measures are appropriate for each patient.

Methods of Venous Thrombosis Prophylaxis

Physical (Mechanical) Measures

Mechanical methods promote blood flow through the veins, reducing the likelihood of clot formation:

Early mobilization: Getting patients up and moving as soon as possible after surgery is one of the most effective preventive strategies.
Compression stockings: Medical thromboprophylaxis stockings apply graduated pressure to the legs, improving venous return.
Intermittent pneumatic compression (IPC): Inflatable cuffs around the legs that rhythmically apply pressure are used particularly when anticoagulant medications are contraindicated.
Leg exercises and physiotherapy: Regular leg movements activate the muscle pump and support venous circulation.

Pharmacological Measures

When the risk of thrombosis is elevated, anticoagulant medications are added to the regimen:

Low molecular weight heparins (LMWH): Administered as a subcutaneous injection, these are the most widely used agents for pharmacological prophylaxis. Examples include enoxaparin and dalteparin.
Unfractionated heparin (UFH): Used as an alternative in specific patient groups, such as those with severe kidney impairment.
Direct oral anticoagulants (DOACs): Agents such as rivaroxaban or apixaban are increasingly used for prophylaxis, particularly after orthopedic procedures.
Fondaparinux: A synthetic anticoagulant administered by subcutaneous injection.
Vitamin K antagonists (e.g., warfarin): Used for longer-term prophylaxis in selected situations, but require regular blood monitoring.

Mechanism of Action of Pharmacological Prophylaxis

Anticoagulant medications intervene at different points along the coagulation cascade – the series of biochemical reactions that lead to clot formation. Heparins enhance the activity of the body's natural anticoagulant antithrombin, while direct oral anticoagulants selectively block specific clotting factors (Factor Xa or thrombin). This reduces the blood's ability to clot without completely preventing normal hemostasis (wound sealing).

Duration of Prophylaxis

How long prophylaxis is required depends on the individual risk profile and underlying condition. After minor procedures, a few days may be sufficient. Following major orthopedic surgeries such as total hip replacement, prophylaxis may continue for up to 35 days. In patients with ongoing elevated risk, such as those with active cancer, long-term prophylaxis may be indicated.

Side Effects and Risks

The most significant risk of pharmacological thromboprophylaxis is an increased tendency to bleed. In rare cases, heparin use can trigger a dangerous immune-mediated reaction called heparin-induced thrombocytopenia (HIT), which paradoxically promotes new clot formation. Regular blood count monitoring is therefore essential. Physical measures such as compression stockings are generally well tolerated but should be used with caution in patients with arterial circulatory disorders.

References

Deutsche Gesellschaft für Angiologie (DGA) – Guideline on the Prevention of Venous Thromboembolism (VTE), AWMF Register No. 065-002, current edition.
Geerts WH et al. – Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2008;133(6 Suppl):381S-453S.
World Health Organization (WHO) – Prevention of Venous Thromboembolism in Hospitalized Patients, WHO Technical Report 2018.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.